What is the appropriate injectable dexamethasone (Dexona) dose for children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Injectable Dexamethasone Dosing in Children

For bacterial meningitis in children, use dexamethasone 0.15 mg/kg every 6 hours for 4 days, starting with or before the first antibiotic dose 1. For croup, a single dose of 0.15 mg/kg (maximum 3 mg) is as effective as the traditional 0.6 mg/kg dose 2, 3, 4.

Context-Specific Dosing

Bacterial Meningitis

  • Dose: 0.15 mg/kg IV every 6 hours for 4 days 1
  • Timing: Must be given with or before the first antibiotic dose; can still be started up to 4 hours after antibiotics if initially missed 1
  • When to stop: Discontinue if the pathogen is NOT Streptococcus pneumoniae or Haemophilus influenzae, or if bacterial meningitis is ruled out 1
  • Not recommended: In neonates (insufficient evidence) 1
  • Evidence strength: This reduces hearing loss and neurologic sequelae in high-income countries with good medical care, though it does not reduce mortality 1

Croup (Laryngotracheobronchitis)

  • Dose: 0.15 mg/kg IV or oral (maximum 3 mg) as a single dose 2, 3
  • Alternative: 0.6 mg/kg (maximum 12 mg) is also effective but offers no additional benefit 2, 3, 4
  • Evidence: Multiple high-quality RCTs demonstrate that 0.15 mg/kg produces equivalent reductions in croup scores at 2,6, and 12 hours, with similar rates of hospital admission and return visits 2, 3, 4
  • Clinical pearl: The lower dose minimizes steroid-related complications while maintaining efficacy 3

Chemotherapy-Induced Nausea/Vomiting (CINV)

  • Highly emetogenic chemotherapy: 12 mg IV on day 1 (when used with NK1 antagonist and 5-HT3 antagonist), then 8 mg daily on days 2-4 5
  • Moderate emetogenic chemotherapy: 8 mg IV on day 1, then 8 mg daily on days 2-4 5
  • Dose adjustment: If NK1 antagonist is NOT used, increase to 20 mg on day 1 and 16 mg on days 2-4 5

General Pediatric Dosing Range

  • FDA guidance: 0.02-0.3 mg/kg/day divided into 3-4 doses for anti-inflammatory indications 6
  • Weight-based considerations: Younger/smaller children (<10 kg) may require higher mg/kg doses due to increased CYP3A4 activity, while older children (>30 kg) require lower mg/kg doses 7, 6

Critical Caveats

When NOT to Use or Use Cautiously

  • Neonatal meningitis: Current evidence insufficient; not recommended 1
  • Hematological malignancies: Risk of tumor lysis syndrome 8
  • Active infections: Weigh risk-benefit carefully, though single doses for meningitis/croup appear safe 1, 2
  • Endocrine testing: Suppresses hypothalamic-pituitary-adrenal axis 8

Monitoring

  • Blood glucose: Expect mild, transient elevation with doses of 4-8 mg 8
  • Wound healing: No increased risk of infection or delayed healing at standard doses 8
  • GI protection: Consider proton pump inhibitor (PPI) with prolonged use, though not typically needed for single-dose croup treatment 6

Comparison: Dexamethasone vs. Prednisolone

For croup, dexamethasone is preferred over prednisolone because it reduces return visits/readmissions by approximately 45% (RR 0.55) and decreases the need for supplemental glucocorticoids by 28% 3. Both show similar croup score reductions at 2 and 6 hours, but dexamethasone's longer half-life provides superior delayed protection.

Key Pitfall to Avoid

Do not routinely prescribe 2 doses of dexamethasone for asthma or croup when discharged from the emergency department. Recent evidence shows that a single dose is sufficient, with no difference in ED revisits or hospitalizations compared to 2-dose regimens 9. The practice of prescribing a second dose persists despite lack of supporting evidence and unnecessarily increases steroid exposure.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.